Sign In
Buy ABCL
$5.80
-0.665 (-10.29%)
At Close: Jul 20, 2026
7 Stocks Under $10 That Analysts Love
07:46pm, Monday, 24'th Apr 2023
Generally speaking, you get what you pay for, which on paper doesn't bode well for these bargain stocks under $10. Nevertheless, with thousands upon thousands of tradable securities available to publi
7 Best Stocks Under $10 to Buy in April
07:31pm, Tuesday, 11'th Apr 2023
Although financial advisors often direct you to established, reliable enterprises, in some cases, you can find compelling ideas among the best stocks under $10. To be fair, such companies tend to be m
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
04:05pm, Tuesday, 11'th Apr 2023
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Present at the 2023 Bloom Burton & Co.
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
01:40pm, Wednesday, 05'th Apr 2023
While it might be difficult to navigate the equities sector now amid various headwinds, biotech stocks to buy may offer a surprising respite. True, the market presence of the surprise production cuts
Confounded's Complete All-Weather Portfolio Revealed
05:17am, Saturday, 01'st Apr 2023
Most readers follow my work for the extensive writing I have done referencing my aggressive growth portfolio. However, the vast majority of my net worth is held in my all-weather portfolio. In this ar
7 Stocks to Bet On if You Want to Be Richer Than Elon Musk
03:26pm, Wednesday, 22'nd Mar 2023
If you aspire to one day topple entrepreneurial genius Elon Musk on the net wealth rankings through the equities market exclusively, you're obviously going to need to conduct heavy research on the sto
AbCellera Biologics Inc (ABCL) Q4 2022 Earnings Call Transcript
07:47pm, Tuesday, 21'st Feb 2023
AbCellera Biologics Inc. (NASDAQ:ABCL ) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Carl Hansen - Chairman, Chi
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates
06:49pm, Tuesday, 21'st Feb 2023
AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -1,100% and 62.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
02:19pm, Thursday, 02'nd Feb 2023
You don't have to be particularly astute to recognize the importance of the most undervalued biotech stocks to buy. Fundamentally, the enterprises that undergird these names operate on the cutting edg
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
04:05pm, Wednesday, 01'st Feb 2023
VANCOUVER, British Columbia--( BUSINESS WIRE )--AbCellera (Nasdaq: ABCL) today announced that it will present at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023, at 10:0
Is the Options Market Predicting a Spike in AbCellera (ABCL) Stock?
10:33am, Tuesday, 24'th Jan 2023
Investors need to pay close attention to AbCellera (ABCL) stock based on the movements in the options market lately.
AbCellera Biologics: My Updated Current Valuation Estimate
02:57am, Thursday, 05'th Jan 2023
In this article, I will provide my valuation model for AbCellera, building on an article I wrote over a year ago. In the last year, many of my inputs I previously used have changed, given the greater
10 Potential 10x Return Stocks For The Next 10 Years
11:04am, Wednesday, 04'th Jan 2023
While others flock to safety, should you do the opposite? Some of the best times to invest in highly speculative names are when no one wants them, as long as the reasons are macro and not company or i
AbCellera Biologics: Q3 Commentary - Moving Up The Value Stack
01:45am, Wednesday, 09'th Nov 2022
AbCellera reported its Q3 earnings on November 8th, solidly beating estimates on both the top and bottom lines. The company, in the days before the release, indicated that Regeneron has advanced its f
AbCellera Biologics Inc (ABCL) Q3 2022 Earnings Call Transcript
09:14pm, Tuesday, 08'th Nov 2022
AbCellera Biologics Inc (NASDAQ:ABCL ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Carl Hansen - Chairman, Chief
